Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Limas Indonesia Makmur Tbk (LMAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Limas Indonesia Makmur TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Limas Indonesia Makmur Tbk dan Brigit Biofarmaka Teknologi Tbk.: Limas Indonesia Makmur Tbk diperdagangkan di Rp50 (kapitalisasi pasar 39,39 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Limas Indonesia Makmur Tbk. Mana yang lebih baik tergantung tujuan investasimu.

LMASOBAT
Kapitalisasi Pasar
39,39 M166,01 M
Volume
324 rb
Lot
3,24 rb
Perputaran
77,68 jt
Harga Rata-rata
239,75
Nilai Transaksi
77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OBAT
Lihat detail

Tentang Limas Indonesia Makmur Tbk

Based in Jakarta and established on June 4th 1996, Limas offers comprehensive financial information services for the financial sector. On 3rd quarter of 1999, S&P Comstocks, Inc appointed the Company as its strategic partner for its data distribution agent in Indonesia. On November 1999, the Company launched its first real time terminal product called StockWatch with extensive tools and coverage for trading on Jakarta Stock Exchange. On January 2000, Limas received endorsements from the Jakarta Stock Exchange to provide its members with the StockWatch terminal. Further endorsements were followed subsequently from Surabaya Stock Exchange to its members on March 2000. On June 2000, the Company launched www.e-bursa.com the first financial sites in local language bahasa. On December 2000, Limas partnered with Dow Jones Newswire to launch the first real time news in bahasa called Dow Jones Limas news. On September 2001, StockWatch version 2.1 was launched and was the first realtime terminal to provide live coverage on Futures trading on the Surabaya Stock Exchange.

Selengkapnya di halaman LMAS

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT